FDA - wireless mobility services - at & t mobility
Active Awarded Last action
- Contract number
- 75F40123A00030
- Awardee
-
Att Mobility LLC UEI P2S7GZFBCSJ1
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Task orders
- 4 $7,745,561 obligated
Award facts
- Opportunity
-
- 75F40123Q00169 Solicitation number
- Combined order value
-
- $7,745,561 Current, with exercised options
- $9,801,425 Potential, with all options
- Last date to order 61% complete
- IDV ceiling 17% used
- $45,000,000.00
- Maximum order
- $45,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 517312 Wireless Telecommunications Carriers (except Satellite)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The Food and Drug Administration established a Blanket Purchase Agreement with AT&T Mobility LLC on September 26, 2023, against the GSA Multiple Award Schedule, with a ceiling of $45 million and an ultimate completion date of September 29, 2028.
The BPA procures wireless mobility services and devices, including wireless telecommunications services, cellular phones, mobile hotspots, and related support. Work is performed at AT&T Mobility's facility in Sandy Springs, Georgia.
Recent BPA-call activity includes three orders issued on September 23, 2024: a $354,000 call exercising option year 1 for wireless services and devices (firm fixed price), and a $7.217 million call exercising option period 2 for wireless telecommunications services and mobile device support (firm fixed price). An earlier call dated September 29, 2023, for $2.106 million covering annual quantities of wireless mobility services was modified on that same date to de-obligate excess funds and close out. A September 28, 2023 call for $123,242.28 provided additional quantities of wireless mobility services through September 2024.
All calls carry firm fixed-price pricing and no small-business set-aside.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75F40123A00030?
75F40123A00030 was awarded to Att Mobility LLC by Food and Drug Administration (Department of Health and Human Services) on September 26, 2023.
How much is contract 75F40123A00030 worth?
Orders under 75F40123A00030 have obligated $7,745,561. Their combined potential value, with all options, is $9,801,425. 75F40123A00030's own ceiling is $45,000,000. A single order can be worth up to $45,000,000.
How many orders have been placed under contract 75F40123A00030?
4 orders have been placed under 75F40123A00030, the latest on September 23, 2024.
Who can order from contract 75F40123A00030?
75F40123A00030 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
Is contract 75F40123A00030 under another contract?
Yes. 75F40123A00030 is a blanket purchase agreement under 47QTCA19D00MV, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40123A00030 competed?
The extent of competition for 75F40123A00030 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV